Evidence map›Paper›PMID 34943654›Full record

ArticleAntibiotics (Basel, Switzerland)2021

New Auranofin Analogs with Antibacterial Properties against

Dustin Maydaniuk, Bin Wu, Dang Truong, Sajani H Liyanage, Andrew M Hogan, Zhong Ling Yap, Mingdi Yan, Silvia T Cardona

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Anti-staphylococcal activity of the auranofin-analogous PEtFrontiers in cellular and infection microbiology · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. A complex bearing TSPO PIGA ligand coordinated to the [Au(PEtBiometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2023
    Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dustin MaydaniukDepartment of Microbiology, University of Manitoba, Winnipeg, MB R3T 2N2, Canada.
Bin WuDepartment of Chemistry, University of Massachusetts, Lowell, MA 01854, USA.
Dang TruongDepartment of Chemistry, University of Massachusetts, Lowell, MA 01854, USA.
Sajani H LiyanageDepartment of Chemistry, University of Massachusetts, Lowell, MA 01854, USA.
Andrew M HoganDepartment of Microbiology, University of Manitoba, Winnipeg, MB R3T 2N2, Canada.ORCID 0000-0002-0782-012X
Zhong Ling YapDepartment of Microbiology, University of Manitoba, Winnipeg, MB R3T 2N2, Canada.
Mingdi YanDepartment of Chemistry, University of Massachusetts, Lowell, MA 01854, USA.ORCID 0000-0003-1121-4007
Silvia T CardonaDepartment of Microbiology, University of Manitoba, Winnipeg, MB R3T 2N2, Canada.ORCID 0000-0002-0629-8886

Funding

Glycosylated Atomically-Precise Gold Clusters: Design, Synthesis and Antimicrobial ActivityR21AI140418 · NIAID · UNIVERSITY OF MASSACHUSETTS LOWELL · PI YAN, MINGDI · 2018 to 2019
$419k
CIHR 169121Cystic Fibrosis Canada 321858National Institute of Allergy and Infectious Diseases R21AI140418
6 · The paper itself

Abstract

Bacteria of the genus

Indexed as

antibiotic resistanceantimicrobialsauranofinBurkholderiaBurkholderia cepacia complexcystic fibrosis

Identifiers

PMID34943654
PMCPMC8697972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.